Merck & Co (NYSE: MRK)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $121.41
-
Support level$108.75
-
Resistance levelN/A
-
Beta0.1
-
RSI (14-day)77.2
- MRK is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- The price of this low-beta stock is expected to increase by 0.1 percent for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- With RSI > 70, MRK is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $73.47 | $121.93 | 99.2% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $89.76 | $108.00 | $113.58 | $118.40 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week5.9%
-
In the next month13.1%
-
In the next year58.1%
| Period | Value |
|---|---|
| Historical (5 year) | 23.2% |
| Last month | 27.8% |
| Current estimate | 21.7% |
| Next month forecast | 23.2% |